AAAAAA
Results:
1-18
|
Results: 18
Authors:
Hoogervorst, ELJ
Kalkers, NF
van Winsen, LML
Uitdehaag, BMJ
Polman, CH
Citation: Elj. Hoogervorst et al., Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis, MULT SCLER, 7(5), 2001, pp. 335-339
Authors:
Killestein, J
Den Drijver, BF
Van der Graaff, WL
Uitdehaag, BMJ
Polman, CH
Van Lier, RAW
Citation: J. Killestein et al., Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease, MULT SCLER, 7(3), 2001, pp. 145-150
Authors:
Uitdehaag, BMJ
Hoekstra, K
Koper, JW
Polman, CH
Dijkstra, CD
Citation: Bmj. Uitdehaag et al., IFN-beta 1b augments glucocorticoid-induced suppression of tumor necrosis factor-alpha production by increasing the number of glucocorticoid receptors on a human monocytic cell line, J INTERF CY, 21(3), 2001, pp. 133-135
Authors:
Polman, CH
Uitdehaag, BMJ
Citation: Ch. Polman et Bmj. Uitdehaag, Drug treatment of multiple sclerosis - Clinical review was unsystematic - Reply, BR MED J, 322(7281), 2001, pp. 299-299
Authors:
Head, MW
Tissingh, G
Uitdehaag, BMJ
Barkhof, F
Bunn, TJR
Ironside, JW
Kamphorst, W
Scheltens, P
Citation: Mw. Head et al., Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: Atypical molecular phenotype, ANN NEUROL, 50(2), 2001, pp. 258-261
Authors:
van Veen, T
Crusius, JBA
Schrijver, HM
Bouma, G
Killestein, J
van Winsen, L
Pena, AS
Polman, CH
Uitdehaag, BMJ
Citation: T. Van Veen et al., Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis, ANN NEUROL, 50(2), 2001, pp. 275-275
Authors:
Hoogervorst, ELJ
van Winsen, LML
Eikelenboom, MJ
Kalkers, NF
Uitdehaag, BMJ
Polman, CH
Citation: Elj. Hoogervorst et al., Comparisons of patient self-report, neurologic examination, and functionalimpairment in MS, NEUROLOGY, 56(7), 2001, pp. 934-937
Authors:
Kalkers, NF
Bergers, L
de Groot, V
Lazeron, RHC
van Walderveen, MAA
Uitdehaag, BMJ
Polman, CH
Barkhof, F
Citation: Nf. Kalkers et al., Concurrent validity of the MS functional composite using MRI as a biological disease marker, NEUROLOGY, 56(2), 2001, pp. 215-219
Authors:
Gerritsen, AAM
Uitdehaag, BMJ
van Geldere, D
Scholten, RJPM
de Vet, HCW
Bouter, LM
Citation: Aam. Gerritsen et al., Systematic review of randomized clinical trials of surgical treatment for carpal tunnel syndrome, BR J SURG, 88(10), 2001, pp. 1285-1295
Authors:
Arnoldus, JHA
Killestein, J
Pfennings, LEMA
Jelles, B
Uitdehaag, BMJ
Polman, CH
Citation: Jha. Arnoldus et al., Quality of life during the first 6 months of interferon-beta treatment in patients with MS, MULT SCLER, 6(5), 2000, pp. 338-342
Authors:
Nijeholt, GJLA
Castelijns, JA
Lazeron, RHC
van Waesberghe, JHTM
Polman, CH
Uitdehaag, BMJ
Barkhof, F
Citation: Gjla. Nijeholt et al., Magnetization transfer ratio of the spinal cord in multiple sclerosis: Relationship to atrophy and neurologic disability, J NEUROIMAG, 10(2), 2000, pp. 67-72
Authors:
Polman, CH
Uitdehaag, BMJ
Citation: Ch. Polman et Bmj. Uitdehaag, Regular review - Drug treatment of multiple sclerosis, BR MED J, 321(7259), 2000, pp. 490-494
Authors:
Nijeholt, GJLA
Uitdehaag, BMJ
Bergers, E
Castelijns, JA
Polman, CH
Barkhof, F
Citation: Gjla. Nijeholt et al., Spinal cord magnetic resonance imaging in suspected multiple sclerosis, EUR RADIOL, 10(2), 2000, pp. 368-376
Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis
Authors:
de Jong, BA
Schrijver, HM
Huizinga, TWJ
Bollen, ELEM
Polman, CH
Uitdehaag, BMJ
Kersbergen, MC
Sturk, A
Westendorp, RGJ
Citation: Ba. De Jong et al., Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis, ANN NEUROL, 48(4), 2000, pp. 641-646
Authors:
Killestein, J
Schrijver, HM
Crusius, JBA
Perez, C
Uitdehaag, BMJ
Pena, AS
Polman, CH
Citation: J. Killestein et al., Intracellular adhesion molecule-1 polymorphisms and genetic susceptibilityto multiple sclerosis: Additional data and meta-analysis, ANN NEUROL, 47(2), 2000, pp. 277-278
Authors:
Polman, CH
Uitdehaag, BMJ
Citation: Ch. Polman et Bmj. Uitdehaag, Drug treatment of multiple sclerosis, WEST J MED, 173(6), 2000, pp. 398-402
Authors:
Nasseri, K
Uitdehaag, BMJ
van Walderveen, MAA
Ader, HJ
Polman, CH
Citation: K. Nasseri et al., Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?, EUR J NEUR, 6(1), 1999, pp. 29-33
Authors:
Schrijver, HM
Crusius, JBA
Uitdehaag, BMJ
Gonzalez, MAG
Kostense, PJ
Polman, CH
Pena, AS
Citation: Hm. Schrijver et al., Association of interleukin-1 beta and interleukin-1 receptor antagonist genes with disease severity in MS, NEUROLOGY, 52(3), 1999, pp. 595-599
Risultati:
1-18
|